The initial aim of this study is to investigate the prevalence of CDH1 pathogenic variants in women with early-onset (<45 or <50) invasive or in situ LBC, bilateral LBC, and LBC without a family history of HDGC. This evidence concerns the gene CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome.